The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer

Urogenital schistosomiasis is a neglected tropical disease that can lead to bladder cancer. How urogenital schistosomiasis induces carcinogenesis remains unclear, although there is evidence that the human blood fluke Schistosoma haematobium , the infectious agent of urogenital schistosomiasis, relea...

Full description

Saved in:
Bibliographic Details
Main Authors: Nuno Vale, Maria J Gouveia, Gabriel Rinaldi, Júlio Santos, Lúcio Lara Santos, Paul J Brindley, José M Correia da Costa
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317692247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849428733561143296
author Nuno Vale
Maria J Gouveia
Gabriel Rinaldi
Júlio Santos
Lúcio Lara Santos
Paul J Brindley
José M Correia da Costa
author_facet Nuno Vale
Maria J Gouveia
Gabriel Rinaldi
Júlio Santos
Lúcio Lara Santos
Paul J Brindley
José M Correia da Costa
author_sort Nuno Vale
collection DOAJ
description Urogenital schistosomiasis is a neglected tropical disease that can lead to bladder cancer. How urogenital schistosomiasis induces carcinogenesis remains unclear, although there is evidence that the human blood fluke Schistosoma haematobium , the infectious agent of urogenital schistosomiasis, releases estradiol-like metabolites. These kind of compounds have been implicated in other cancers. Aiming for enhanced understanding of the pathogenesis of the urogenital schistosomiasis-induced bladder cancer, here we review, interpret, and discuss findings of estradiol-like metabolites detected in both the parasite and in the human urine during urogenital schistosomiasis. Moreover, we predict pathways and enzymes that are involved in the production of these metabolites emphasizing their potential effects on the dysregulation of the tumor suppressor gene p53 expression during urogenital schistosomiasis. Enhanced understanding of these potential carcinogens may not only shed light on urogenital schistosomiasis-induced neoplasia of the bladder, but would also facilitate development of interventions and biomarkers for this and other infection-associated cancers at large.
format Article
id doaj-art-3295eabc299845f68bb2f14967607b9c
institution Kabale University
issn 1423-0380
language English
publishDate 2017-03-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-3295eabc299845f68bb2f14967607b9c2025-08-20T03:28:37ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317692247The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancerNuno Vale0Maria J Gouveia1Gabriel Rinaldi2Júlio Santos3Lúcio Lara Santos4Paul J Brindley5José M Correia da Costa6UCIBIO/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, PortugalCenter for the Study of Animal Science, ICETA, University of Porto, Porto, PortugalThe Wellcome Trust Sanger Institute, Cambridge, UKExperimental Pathology and Therapeutics Group, Research Center of Instituto Português de Oncologia, Porto, PortugalExperimental Pathology and Therapeutics Group, Research Center of Instituto Português de Oncologia, Porto, PortugalDepartment of Microbiology, Immunology, & Tropical Medicine and Research Center for Neglected Diseases of Poverty, School of Medicine & Health Sciences, George Washington University, Washington, DC, USADepartment of Infectious Diseases, R&D Unit, National Health Institute Doutor Ricardo Jorge (INSA), Porto, PortugalUrogenital schistosomiasis is a neglected tropical disease that can lead to bladder cancer. How urogenital schistosomiasis induces carcinogenesis remains unclear, although there is evidence that the human blood fluke Schistosoma haematobium , the infectious agent of urogenital schistosomiasis, releases estradiol-like metabolites. These kind of compounds have been implicated in other cancers. Aiming for enhanced understanding of the pathogenesis of the urogenital schistosomiasis-induced bladder cancer, here we review, interpret, and discuss findings of estradiol-like metabolites detected in both the parasite and in the human urine during urogenital schistosomiasis. Moreover, we predict pathways and enzymes that are involved in the production of these metabolites emphasizing their potential effects on the dysregulation of the tumor suppressor gene p53 expression during urogenital schistosomiasis. Enhanced understanding of these potential carcinogens may not only shed light on urogenital schistosomiasis-induced neoplasia of the bladder, but would also facilitate development of interventions and biomarkers for this and other infection-associated cancers at large.https://doi.org/10.1177/1010428317692247
spellingShingle Nuno Vale
Maria J Gouveia
Gabriel Rinaldi
Júlio Santos
Lúcio Lara Santos
Paul J Brindley
José M Correia da Costa
The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
Tumor Biology
title The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
title_full The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
title_fullStr The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
title_full_unstemmed The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
title_short The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer
title_sort role of estradiol metabolism in urogenital schistosomiasis induced bladder cancer
url https://doi.org/10.1177/1010428317692247
work_keys_str_mv AT nunovale theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT mariajgouveia theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT gabrielrinaldi theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT juliosantos theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT luciolarasantos theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT pauljbrindley theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT josemcorreiadacosta theroleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT nunovale roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT mariajgouveia roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT gabrielrinaldi roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT juliosantos roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT luciolarasantos roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT pauljbrindley roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer
AT josemcorreiadacosta roleofestradiolmetabolisminurogenitalschistosomiasisinducedbladdercancer